Bicarbonate

Indications

For treatment of metabolic acidosis. See package insert for specific indications. Active Ingredient : Each mL contains: Sodium Bicarbonate..........................84 mg (equal to 1 mEq/mL) Inactive Ingredient: Water for Injection...........................q.s.

Dosage and Administration

Administer intravenously. See package insert for complete directions for use and dosage information. Take Time Observe Label Directions NDC 13985-567-01 100 mL VetOne ® Sodium Bicarbonate 8.4% Injection Sterile Solution Single Dose Vial V1 510186 Net Contents: 100 mL Made In USA of U.S. and imported materials. Distributed by:MWI Boise, ID 83705 www.VetOne.net

Warnings

This is a sterile single dose vial. No preservatives have been added. Discard unused portion after use. Do not use if solution is hazy, cloudy, or contains a precipitate. The total osmolar concentration of this product is approximately 2000 mOsm/L. Read entire package insert before use. Package Insert VetOne® SODIUM BICARBONATE 8.4% Injection STERILE NONPYROGENIC SOLUTION FOR VETERINARY USE ONLY DESCRIPTION: Sodium Bicarbonate 8.4% is a sterile nonpyrogenic preparation of sodium bicarbonate (NaHCO3) in Water for Injection. Each 100 mL contains 8.4 grams of sodium bicarbonate (100 mEq/100 mL each of sodium and bicarbonate). This concentrated solution has an approximate pH of 7.8. ACTIONS: Sodium Bicarbonate is useful in the treatment of metabolic acidosis due to a wide variety of causes. Sodium Bicarbonate therapy increases plasma bicarbonate, buffers excess hydrogen ion concentration, raises blood pH and reverses the clinical manifestations of acidosis. Sodium Bicarbonate also alkalinizes the urine. INDICATIONS: Sodium Bicarbonate is indicated in the treatment of metabolic acidosis which may be due to severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, cardiac arrest and severe primary lactic acidosis. Sodium Bicarbonate is also indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Sodium Bicarbonate 8.4% is indicated in the treatment of metabolic acidosis in cattle, horses, sheep, swine and dogs depending upon causative factor. CONTRAINDICATIONS: Sodium Bicarbonate is contraindicated in animals losing chloride by vomiting and in animals receiving diuretics known to produce a hypochloremic alkalosis. PRECAUTIONS: Bicarbonate therapy is directed at producing a substantial correction of low total CO2 content and blood pH, but risks of overdosage and alkalosis should be avoided. Repeated fractional doses and periodic monitoring by appropriate laboratory tests are therefore recommended to minimize the possibility of overdosage. Sodium Bicarbonate addition to parenteral solutions containing calcium should be avoided except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures, and the resulting solution should not be administered. DOSAGE AND ADMINISTRATION: Sodium Bicarbonate 8.4% is injected intravenously. Caution should be taken in emergencies where very rapid infusion of large quantities of bicarbonate is indicated, such as cardiac arrest. Sodium Bicarbonate solutions are hypertonic and may produce an undesirable rise in plasma sodium concentration during the process of correction of metabolic acidosis. During cardiac arrest, however, the risks from acidosis exceed those of hypernatremia. In cattle and horses, 200 to 300 mL of 8.4% solution may be given undiluted by rapid infusion using a needle and syringe. Sodium Bicarbonate 8.4% solution is often added to other intravenous fluids for the less urgent forms of metabolic acidosis. The amount of bicarbonate to be given over a 4 to 8 hour period is approximately 2 to 5 mEq per kg of body weight (1-2.5 mL/lb body weight) depending upon the severity of the acidosis as judged by the lowering of total CO2 content, blood pH and clinical condition of the animal. Bicarbonate therapy should always be planned in stepwise fashion since the degree of response from a given dose is not precisely predictable. Initially, an infusion of 2 to 5 mEq per kg of body weight over a period of 4 to 8 hours will produce a measurable improvement in the abnormal acid-base status of the blood. Completion of therapy is dependent upon the clinical response of the animal. If severe symptoms have abated, then frequency of administration and size of the dose should be reduced. OVERDOSAGES: In case alkalosis occurs, the bicarbonate should be stopped and the animal managed according to the degree of alkalosis present. Sodium chloride injection (0.9%) may be given intravenously; potassium chloride also may be indicated if there is hypokalemia. Severe alkalosis may be accompanied by hyperirritability or tetany, and these symptoms may be controlled by calcium gluconate. An acidifying agent such as ammonium chloride may also be indicated in severe alkalosis. HOW SUPPLIED: Sodium Bicarbonate 8.4% is supplied in a 100 mL single dose vial. WARNING: This is a sterile single dose vial. No preservatives have been added. Discard unused portion after use. Do not use if solution is hazy, cloudy or contains a precipitate. Store at a temperature between 15°-30° C (59°-86° F). CAUTION: Federal law (U.S.A.) restricts this drug to use by or on the order of a licensed veterinarian. Questions? Call 859-254-1221 or toll-free 800-621-8829. Distributed by: MWI Boise, ID 83705 www.VetOne.net VetOne ® Sodium Bicarbonate Sodium Bicarbonate MWI.jpg

Storage

Store at a temperature between 15°-30°C (59°-86°F). Avoid freezing. Keep out of reach of children. For veterinary use only. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Other labels for this ingredient

These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.

• Neogen®Vet Sodium Bicarbonate 8.4%, Neogen Corporation. Set id 73f26ce4-b393-4f21-93ba-880e9dce6c9d.

FDA adverse event reports

The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming bicarbonate as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.

These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.